95 related articles for article (PubMed ID: 8768733)
1. Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
Chiu T; Reid IA
J Pharmacol Exp Ther; 1996 Aug; 278(2):793-9. PubMed ID: 8768733
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram.
Chiu N; Park I; Reid IA
J Pharmacol Exp Ther; 1996 Mar; 276(3):1073-7. PubMed ID: 8786537
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphodiesterase III with milrinone increases renin secretion in human subjects.
Chiu YJ; Hu SH; Reid IA
J Pharmacol Exp Ther; 1999 Jul; 290(1):16-9. PubMed ID: 10381754
[TBL] [Abstract][Full Text] [Related]
4. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
Beierwaltes WH
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
6. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
[TBL] [Abstract][Full Text] [Related]
8. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway.
Reilly CM; Lewis RW; Stopper VS; Mills TM
J Androl; 1997; 18(6):588-94. PubMed ID: 9432131
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
[TBL] [Abstract][Full Text] [Related]
11. Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney.
Scholz H; Kurtz A
J Clin Invest; 1993 Mar; 91(3):1088-94. PubMed ID: 8383697
[TBL] [Abstract][Full Text] [Related]
12. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed.
McCulloch AI; Bottrill FE; Randall MD; Hiley CR
Br J Pharmacol; 1997 Apr; 120(8):1431-8. PubMed ID: 9113362
[TBL] [Abstract][Full Text] [Related]
13. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
14. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.
Lugnier C; Komas N
Eur Heart J; 1993 Nov; 14 Suppl I():141-8. PubMed ID: 8293765
[TBL] [Abstract][Full Text] [Related]
15. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
16. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 beta induces the formation of nitric oxide in isolated juxtaglomerular cells: influence on renin secretion.
Galle J; Schini VB; Stunz P; Wanner C; Schollmeyer P
Nephrol Dial Transplant; 1995; 10(2):191-7. PubMed ID: 7538649
[TBL] [Abstract][Full Text] [Related]
18. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy.
Straznicka M; Leone RJ; Scholz PM; Weiss HR
J Surg Res; 1998 Apr; 76(1):61-6. PubMed ID: 9695741
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.
Reid IA; Bui H; Chou L
Hypertension; 1994 Jan; 23(1 Suppl):I49-53. PubMed ID: 8282375
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
